JPMorgan Chase & Co. Issues Positive Forecast for AtriCure (NASDAQ:ATRC) Stock Price
AtriCure (NASDAQ:ATRC – Free Report) had its price target boosted by JPMorgan Chase & Co. from $40.00 to $51.00 in a research report released on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. A number of other equities analysts have also recently issued reports on […]
AtriCure (NASDAQ:ATRC – Free Report) had its price target boosted by JPMorgan Chase & Co. from $40.00 to $51.00 in a research report released on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. A number of other equities analysts have also recently issued reports on […]
